References
Bruix J, Sherman M. American association for the study of liver diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–2.
Papageorge MV, Woods AP, de Geus SWL, et al. Beyond insurance status: the impact of medicaid expansion on the diagnosis of hepatocellular carcinoma. HPB (Oxford). 2022;24(8):1271–9.
Elshami M, Hoehn R, Hue JJ, et al. Medicaid expansion is associated with a higher likelihood of early diagnosis, resection, transplantation, and overall survival in patients with hepatocellular carcinoma. HPB (Oxford). 2022;24(9):1482–91.
Kaelberer Z, Ruan M, Lam MB, Brindle M, Molina G. Medicaid expansion and surgery for HPB/GI cancers: NCDB difference-in-difference analysis. Am J Surg. 2023;225(2):328–34.
Lima HA, Endo Y, Zorays M, et al. The impact of medicaid expansion on early-stage hepatocellular carcinoma care. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-13562-9.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
The authors have nothing to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lima, H.A., Moazzam, Z., Endo, Y. et al. ASO Author Reflections: The Impact of Medicaid Expansion on Early-Stage Hepatocellular Carcinoma Care. Ann Surg Oncol 30, 4600–4601 (2023). https://doi.org/10.1245/s10434-023-13563-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-13563-8